Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

EXAGEN INC. Director's Dealing 2020

Mar 26, 2020

33644_dirs_2020-03-26_d13db1e1-dd15-4605-bd58-e56dce628e61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2020-03-24

Reporting Person: Zack Debra (Chief Medical Officer)

More from EXAGEN INC.

Declaration of Voting Results & Voting Rights Announcements 2026
Jun 9
Share Issue/Capital Change 2026
May 12
Interim / Quarterly Report 2026
May 11
Earnings Release 2026
May 11
Annual Report 2026
Apr 27
Proxy Solicitation & Information Statement 2026
Apr 27
Board/Management Information 2026
Apr 23
Call Transcript 2026
Mar 10
Director's Dealing 2026
Feb 25
Director's Dealing 2026
Feb 25
View all filings →